The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvatinib as first-line treatment for advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial.
 
Zhou Jian
No Relationships to Disclose
 
Jia Fan
No Relationships to Disclose
 
Guo-Ming Shi
No Relationships to Disclose
 
Xiao-Yong Huang
No Relationships to Disclose
 
Dong Wu
No Relationships to Disclose
 
Guo-Huan Yang
No Relationships to Disclose
 
Yuan Ji
No Relationships to Disclose
 
Yi Chen
No Relationships to Disclose
 
Fei Liang
No Relationships to Disclose
 
Jia-Cheng Lu
No Relationships to Disclose
 
Ning-Ling Ge
No Relationships to Disclose
 
Hui-Chuan Sun
No Relationships to Disclose
 
Xiao-Wu Huang
No Relationships to Disclose
 
Shuang-Jian Qiu
No Relationships to Disclose
 
Yi-Feng He
No Relationships to Disclose
 
Xin-Rong Yang
No Relationships to Disclose
 
Yang Xu
No Relationships to Disclose
 
Qiang Gao
No Relationships to Disclose
 
Jian Sun
No Relationships to Disclose